DE60130994T2 - Anti-hiv und anti-tumor lysozympeptide sowie fragmente - Google Patents

Anti-hiv und anti-tumor lysozympeptide sowie fragmente Download PDF

Info

Publication number
DE60130994T2
DE60130994T2 DE60130994T DE60130994T DE60130994T2 DE 60130994 T2 DE60130994 T2 DE 60130994T2 DE 60130994 T DE60130994 T DE 60130994T DE 60130994 T DE60130994 T DE 60130994T DE 60130994 T2 DE60130994 T2 DE 60130994T2
Authority
DE
Germany
Prior art keywords
hiv
lysozyme
fragment
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60130994T
Other languages
German (de)
English (en)
Other versions
DE60130994D1 (de
Inventor
Sylvia New York LEE-HUANG
Philip L. Boston HUANG
Paul Boston HUANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University
Original Assignee
New York University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University filed Critical New York University
Publication of DE60130994D1 publication Critical patent/DE60130994D1/de
Application granted granted Critical
Publication of DE60130994T2 publication Critical patent/DE60130994T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60130994T 2000-07-07 2001-07-09 Anti-hiv und anti-tumor lysozympeptide sowie fragmente Expired - Lifetime DE60130994T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21670200P 2000-07-07 2000-07-07
US216702P 2000-07-07
PCT/US2001/021582 WO2002004011A1 (en) 2000-07-07 2001-07-09 Anti-hiv and anti-tumor peptides and fragments of lysozyme

Publications (2)

Publication Number Publication Date
DE60130994D1 DE60130994D1 (de) 2007-11-29
DE60130994T2 true DE60130994T2 (de) 2008-07-24

Family

ID=22808164

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130994T Expired - Lifetime DE60130994T2 (de) 2000-07-07 2001-07-09 Anti-hiv und anti-tumor lysozympeptide sowie fragmente

Country Status (8)

Country Link
US (1) US7838275B2 (enExample)
EP (1) EP1303291B1 (enExample)
JP (1) JP2004505616A (enExample)
AT (1) ATE375800T1 (enExample)
AU (1) AU2001278884A1 (enExample)
CA (1) CA2415083A1 (enExample)
DE (1) DE60130994T2 (enExample)
WO (1) WO2002004011A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1518557A4 (en) * 2002-06-28 2008-12-03 Fuso Pharmaceutical Ind ANTI-HIV AGENTS
ITMI20061950A1 (it) * 2006-10-11 2008-04-12 Therapicon Srl Effetto antimetastatico in condizioni patologiche delle cellule umane
RU2009136424A (ru) * 2007-03-02 2011-04-10 СЕНТ СИМЕОН ЭлДиЭй (US) Композиция и способ лечения папилломавируса и саркоидов лошадей
CN106029089B (zh) * 2014-02-21 2020-12-29 丘比株式会社 诺如病毒灭活剂及其制造方法
CN113861760B (zh) 2016-12-28 2023-05-05 Dic株式会社 分散体
CN110438106B (zh) * 2019-08-06 2021-03-23 北京华韵国丰新材料科技有限公司 一种人工设计的纳米溶菌酶和纳米溶菌酶的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554501A (en) 1992-10-29 1996-09-10 Beckman Instruments, Inc. Biopolymer synthesis using surface activated biaxially oriented polypropylene
US5583211A (en) * 1992-10-29 1996-12-10 Beckman Instruments, Inc. Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides
JPH06211692A (ja) * 1993-01-21 1994-08-02 Nippon Oil Co Ltd 免疫増強剤
EP0721458B1 (en) 1993-09-28 2000-05-17 Beckman Coulter, Inc. Biopolymer synthesis utilizing surface activated, organic polymers
AU3307497A (en) * 1996-06-26 1998-01-14 Antigen Express, Inc. Immunotherapy by modulation of antigen presentation
WO1998026747A2 (en) * 1996-12-17 1998-06-25 Terman David S Superantigen based methods and compositions for treatment of diseases
GB9907366D0 (en) 1999-03-30 1999-05-26 Medical Res Council Method for expressing proteins

Also Published As

Publication number Publication date
EP1303291A4 (en) 2005-04-06
DE60130994D1 (de) 2007-11-29
US20050008631A1 (en) 2005-01-13
ATE375800T1 (de) 2007-11-15
EP1303291A1 (en) 2003-04-23
EP1303291B1 (en) 2007-10-17
US7838275B2 (en) 2010-11-23
WO2002004011A1 (en) 2002-01-17
AU2001278884A1 (en) 2002-01-21
JP2004505616A (ja) 2004-02-26
CA2415083A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
DE69818445T2 (de) Verwendung von verbindungen die an ein zytoplasmatischen dipeptidase binden zur potenzierung des immunantworts
AT392081B (de) Verfahren zur herstellung eines arzneimittels zur behandlung von virusinfektionen
EP0142860B1 (de) Desulfatohirudine, Verfahren zu ihrer Herstellung und pharmazeutische Mittel
DE69020573T2 (de) Verfahren zur wachstumshemmung von stammzellen.
DE19622222A1 (de) Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
DD298412A5 (de) Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele
DE3448145C2 (enExample)
EP0467337B1 (de) Konservierung von diagnostischen Tests
DE69327153T2 (de) Anti-hiv-medikament
DE3026180A1 (de) Verwendung von rifamycin sv und seinen salzen in form von praeparaten zur intraartikulaeren injektion bei der bekaempfung von rheumatoider arthritis
DE69210797T2 (de) Prolyl Endopeptidase Inhibitor
DE69322654T2 (de) Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle
DE69230835T2 (de) Behandlung von protozoalen infekten mit bacitracin
EP1303291B1 (en) Anti-hiv and anti-tumor peptides and fragments of lysozyme
DE69624105T2 (de) Inhibitoren der metazoenparasiten-proteasen
Broome et al. A new drug for the treatment of fascioliasis in sheep and cattle
DE68924222T2 (de) Megakaryocytopoietin, seine Herstellung und Benutzung.
DE69812010T2 (de) 4-Aminopyrrole (3,2-d) Pyrimidinen als Antagonisten des Neuropeptide Y Receptors
DE69431430T2 (de) Faktor XIII zur Behandlung von Hautwunden
EP0119990A2 (de) Verfahren zur Herstellung von therapeutisch verabreichbaren, in Endbehältern abgefüllten Plasmaderivaten
DE3780343T2 (de) Antivirale 8-phenylxanthine.
WO2001080871A2 (de) Anwendung von guanylat-zyklase-c (gc-c) agonisten als insulinotrope faktoren zur behandlung von diabetes mellitus typ 2
DE69928685T2 (de) Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit
DE202022102358U1 (de) Zusammensetzung zur Behandlung von Alpha-Thalassämie mit Hämoglobinproduktion
DE69202136T2 (de) Neuartiges calcitonin, und seine herstellung und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition